ask="12.50"
ask_size="100"
average_daily_volume="31117"
bid="3.12"
bid_size="100"
book_value="3.34"
change="+0.16"
change_from_200_day_moving_average="4.94"
change_from_50_day_moving_average="2.38"
change_from_52_week_high="-0.79"
change_From_52_week_low="8.44"
change_in_percent="+1.36%"
close="11.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.53"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="12.00"
high_52_weeks="12.75"
last_trade_date="3/8/2017"
last_trade_price="11.96"
last_trade_size="148"
last_trade_time="4:00pm"
low="11.64"
low_52_weeks="3.52"
market_capitalization="254.51M"
moving_average_200_day="7.02"
moving_average_50_day="9.58"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.81"
open="11.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+70.37%"
percent_change_from_50_day_moving_average="+24.80%"
percent_change_from_52_week_high="-6.20%"
percent_change_from_52_week_low="+239.77%"
previous_close="11.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.53"
price_per_sales="48.29"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.35"
stock_exchange="NMS"
symbol="NBRV"
volume="18592"
weeks_range_52="3.52 - 12.75"
